[go: up one dir, main page]

AR021502A1 - USE OF N-SUBSTITUTED AZABICICLOALCAN DERIVATIVES FOR THE TREATMENT OF NERVOUS CENTRAL SYSTEM DISEASES - Google Patents

USE OF N-SUBSTITUTED AZABICICLOALCAN DERIVATIVES FOR THE TREATMENT OF NERVOUS CENTRAL SYSTEM DISEASES

Info

Publication number
AR021502A1
AR021502A1 ARP990105979A ARP990105979A AR021502A1 AR 021502 A1 AR021502 A1 AR 021502A1 AR P990105979 A ARP990105979 A AR P990105979A AR P990105979 A ARP990105979 A AR P990105979A AR 021502 A1 AR021502 A1 AR 021502A1
Authority
AR
Argentina
Prior art keywords
treatment
substituted
derivatives
azabicicloalcan
central system
Prior art date
Application number
ARP990105979A
Other languages
Spanish (es)
Original Assignee
Basf Se
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Se filed Critical Basf Se
Publication of AR021502A1 publication Critical patent/AR021502A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Se describe el uso de derivados de azabicicloalcanos N-sustituidos de la formula (1) donde: B, R1, R2 y n tienen los significados indicados en ladescripcion, para el tratamiento de enfermedades de adiccion y otras enfermedades del sistema central nervioso.The use of N-substituted azabicycloalkane derivatives of the formula (1) is described where: B, R1, R2 and n have the meanings indicated in the description, for the treatment of addiction diseases and other diseases of the central nervous system.

ARP990105979A 1998-11-24 1999-11-24 USE OF N-SUBSTITUTED AZABICICLOALCAN DERIVATIVES FOR THE TREATMENT OF NERVOUS CENTRAL SYSTEM DISEASES AR021502A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19854147A DE19854147A1 (en) 1998-11-24 1998-11-24 Control of cocaine addiction comprises administration of N-substituted azabicycloalkane derivative

Publications (1)

Publication Number Publication Date
AR021502A1 true AR021502A1 (en) 2002-07-24

Family

ID=7888824

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990105979A AR021502A1 (en) 1998-11-24 1999-11-24 USE OF N-SUBSTITUTED AZABICICLOALCAN DERIVATIVES FOR THE TREATMENT OF NERVOUS CENTRAL SYSTEM DISEASES

Country Status (21)

Country Link
EP (1) EP1133293A1 (en)
JP (1) JP2002530333A (en)
KR (1) KR20010080535A (en)
CN (1) CN1328455A (en)
AR (1) AR021502A1 (en)
AU (1) AU1775300A (en)
BG (1) BG105549A (en)
BR (1) BR9915589A (en)
CA (1) CA2352526A1 (en)
CZ (1) CZ20011796A3 (en)
DE (1) DE19854147A1 (en)
HK (1) HK1040933A1 (en)
HR (1) HRP20010472A2 (en)
HU (1) HUP0104416A3 (en)
IL (1) IL143181A0 (en)
NO (1) NO20012538L (en)
PL (1) PL348758A1 (en)
SK (1) SK7112001A3 (en)
TR (1) TR200101476T2 (en)
WO (1) WO2000030639A1 (en)
ZA (1) ZA200103976B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2589363A1 (en) 2004-12-13 2006-06-22 Eli Lilly And Company Spiro derivatives as lipoxygenase inhibitors
GB0812310D0 (en) 2008-07-03 2008-08-13 Syngenta Ltd Novel herbicides
JP2016508159A (en) * 2013-01-15 2016-03-17 ノバルティス アーゲー Use of alpha 7 nicotinic acetylcholine receptor agonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989004311A1 (en) * 1987-11-12 1989-05-18 American Home Products Corporation Polycyclicamines with psychotropic activity
DE4427648A1 (en) * 1994-08-04 1996-02-08 Basf Ag N-Stubstituted 3-azabicyclo [3,2,0,] heptane derivatives, their preparation and use
DE4341403A1 (en) * 1993-12-04 1995-06-08 Basf Ag N-substituted 3-azabicycloalkane derivatives, their preparation and use
DE4427647A1 (en) * 1994-08-04 1996-02-08 Basf Ag N-substituted azabicycloheptane derivatives, their preparation and use

Also Published As

Publication number Publication date
PL348758A1 (en) 2002-06-03
CA2352526A1 (en) 2000-06-02
SK7112001A3 (en) 2001-12-03
BG105549A (en) 2001-12-29
EP1133293A1 (en) 2001-09-19
CN1328455A (en) 2001-12-26
NO20012538L (en) 2001-07-04
JP2002530333A (en) 2002-09-17
IL143181A0 (en) 2002-04-21
HRP20010472A2 (en) 2003-04-30
CZ20011796A3 (en) 2002-05-15
DE19854147A1 (en) 2000-05-25
HUP0104416A2 (en) 2002-04-29
HK1040933A1 (en) 2002-06-28
TR200101476T2 (en) 2001-10-22
NO20012538D0 (en) 2001-05-23
HUP0104416A3 (en) 2002-11-28
ZA200103976B (en) 2002-05-16
AU1775300A (en) 2000-06-13
WO2000030639A1 (en) 2000-06-02
KR20010080535A (en) 2001-08-22
BR9915589A (en) 2001-08-07

Similar Documents

Publication Publication Date Title
DK0585328T3 (en) Substituted 3-aminoquinuclidines
NO931635D0 (en) PROCEDURE FOR THE PREPARATION OF CHINAZOLINE DERIVATIVES
ES2167377T3 (en) DERIVATIVES OF PIRIDINA PHARMACOLOGICALLY ACTIVE AND PROCEDURES FOR THE PREPARATION OF THE SAME.
AR010062A1 (en) NEW BENZAMIDALDEHYDE AND ITS USE
CY1108339T1 (en) SPIRO DERIVATIVES (2H-1-BENZOPYRAN-2,4IP-PIPERIDINE) AS GLYCINE TRANSPORT INHIBITORS
ATE69951T1 (en) CANCEROSTATIC AGENT.
BR0015416A (en) Compositions containing tetraenoic hydroxyieic acid derivatives and methods of use in the treatment of dry eye disorders
BR0316296A (en) Lapacone compounds and their methods of use
ES2063202T3 (en) NEW 5,11-DIHIDRO-6H-DIPIRIDO (3,2-B: 2 ', 3'-E) (1,4) DIAZEPIN-6-ONAS Y -TIONAS AND ITS USE IN THE PREVENTION OR TREATMENT OF AIDS.
AR028705A1 (en) BIS-ARILSULPHONES
HN1999000146A (en) PHARMACEUTICAL AGENTS FOR THE TREATMENT OF PARKINSON'S DISEASE, ADHD AND MICROADENOMAS.
ES2101858T3 (en) GENESERINE DERIVATIVES AS CHOLINESTERASE INHIBITORS.
EA200200742A1 (en) 1,2-DIARYLBENZYMIDAZOLEY FOR THE TREATMENT OF DISEASES ASSOCIATED WITH THE ACTIVATION OF MICROGLY
ES2084996T3 (en) SUBSTITUTED PIPERAZINES USEFUL AS AGENTS FOR THE CENTRAL NERVOUS SYSTEM.
DE60115466D1 (en) ACTIVE PROCESSORS OF IMIDAZOPYRIDINE DERIVATIVES
TR200101149T2 (en) Treatment of external retinal disorders.
ATE369348T1 (en) CYCLIZED BENZAMIDE NEUROKININ ANTAGONISTS FOR USE IN THERAPY
TR200001102T2 (en) Substituted tetrahydropyrimidinene derivatives, their production and uses.
AR020563A1 (en) TIA-ALQUINOIC COMPOUNDS (POLI) AND THEIR DERIVATIVES, COMPOSITIONS THAT INCLUDE THEM AND THEIR USE
ATE236134T1 (en) ISOQUINOLINAMINE AND PHTALAZINAMINE DERIVATIVES THAT REACT WITH CRF RECEPTORS
ATE330958T1 (en) PYRAZINO 1'2':1,6ÖPYRIDO 3,4-BÖINDOL DERIVATIVES
PT916670E (en) PYRROLE- (3,2-B) PYRIDINES AND THEIR USE AS 5-HT1F AGONISTS
ES2196069T3 (en) MORFINOID DERIVATIVES CONDENSED WITH HETEROCICLES.
NO991734L (en) Pyrazolinones for the treatment of potency disorders
MX9700813A (en) New 3-substituted 3h-2,3-benzodiazepine derivatives, their preparation and use as medicaments.